GSK Investigational Site

Lafayette, Indiana 47905

0 studies enrolling now · 16 studies all time

What they study most

Asthma, Bipolar Disorder, Depressive Disorder, Major, Diabetes Mellitus, Type 2, HIV Infection, Major Depressive Disorder (MDD), Measles, Mumps, Pulmonary Disease, Chronic Obstructive, Rhinitis, Allergic, Seasonal, Rubella, Varicella

Studies at this site

• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age — Completed
• A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD — Completed
• Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks — Completed
• A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD — Completed
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR) — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
• Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine — Completed
• GSK BHR Study (Sont) — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• Depression Study In Elderly Patients — Completed
• An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder — Completed
• Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure — Completed